CHUGAI PHARMACEUTICAL CO., LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,049 JPY | +0.26% |
|
+5.27% | -5.45% |
| 05-14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| 05-01 | Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation | MT |
Presenter SpeechYoshio Itaya (Executives)Good morning, ladies and gentlemen. I am Yoshio Itaya...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
5,036
JPY
Average target price
6,021
JPY
Spread / Average Target
+19.57%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.45% | 53B | |
| +34.35% | 693B | |
| +29.39% | 584B | |
| -3.49% | 372B | |
| +20.15% | 332B | |
| +6.19% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +9.21% | 168B |
- Stock Market
- Equities
- 4519 Stock
- News Chugai Pharmaceutical Co., Ltd
- Transcript : Chugai Pharmaceutical Co. Ltd., Q2 2016 Earnings Call, Jul 22, 2016